EnWave Corporation

EnWave Corporation

February 05, 2010 10:00 ET

EnWave Named to TSX Venture Top 50

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 5, 2010) - EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company") has been named as one of the TSX Venture Top 50 companies for 2010, an annual ranking of Canada's top 50 emerging companies. The TSX Venture 50 includes the top 10 companies in 5 major industry sectors that have been identified as leaders in Canada's public venture market. EnWave was ranked fourth in the list of ten leading Canadian Technology and Life Sciences companies for the year.

"With almost 2,200 companies listed on the TSX Venture exchange we are very honoured to be named as one of this year's TSX Venture Top 50 companies," said John McNicol, Co-CEO, EnWave Corporation. "Thanks to the innovation and hard work of EnWave's team, the EnWave story is starting to gain traction throughout the Canadian investment community, and investors are recognizing the value as we move our technology development from proof-of-concept stage to commercialization."

"We are pleased to celebrate the 2010 TSX Venture 50," said John McCoach, President, TSX Venture Exchange. "These outstanding companies are proven leaders in their respective sectors and we are proud to have them listed on TSX Venture Exchange. We wish them all continued success."

The 2010 TSX Venture 50 were selected based on four equally weighted criteria that include return on investment, trading, analyst coverage and market capitalization growth in the Cleantech, Diversified Industries, Mining, Oil & Gas and Technology and Life Sciences sectors.

The TSX Venture Exchange includes companies with a diverse mix of industry sectors, including mining, energy, industrial, life sciences, technology, cleantech and financial services. The Exchange's total market capitalization is over $30 billion. More information about the Top 50 list is available at the following link: www.tsx.com.

About EnWave

Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREV®, powderREV®, bioREV® and freezeREV® brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies. More information about EnWave is available at www.enwave.net.

EnWave Corporation

Mr. John McNicol
President & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. There is no guarantee that the Company's REV technology can or will improve processes in the target industry; even if the Company's REV technology can be used as described in this document, there is no guarantee that such use will result in orders for the Company's REV technology. All figures comparing REV technologies to freeze drying or other dehydration technologies are provided as examples of data obtained through the Company's own scientific and testing programs; each product must be tested individually to determine the benefits of using REV.

The TSX Venture Exchange has neither approved nor disapproved the information contained herein. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information